Search research articles
Contact Us
Filters
Showing results (271-280 of 284) with videos related to
Page
of 29
Sort By:
Journal of Hypertension
|
June 1, 1993
Antihypertensive activity of verapamil: impact of dietary sodium. The VERSAL Study Group
J Redón-Más, J Abellán-Alemán, P Aranda-Lara, et al.
Hypertension (Dallas, Tex. : 1979)
|
October 20, 2001
Impairment of renal vasodilation with l-arginine is related to more severe disease in untreated hypertensive patients
E Bello, C Caramelo, N Martell, et al.
Expert Review of Proteomics
|
June 15, 2019
Proteomic investigations into hypertension: what's new and how might it affect clinical practice?
N Corbacho-Alonso, E Rodríguez-Sánchez, T Martin-Rojas, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 3, 1999
Induction of microalbuminuria by l-arginine infusion in healthy individuals: an insight into the mechanisms of proteinuria
E Bello, C Caramelo, M D López, et al.
Journal of Human Hypertension
|
June 26, 2015
Modification over time of pulse wave velocity parallel to changes in aortic BP, as well as in 24-h ambulatory brachial BP
A Oliveras, J Segura, C Suarez, et al.
Hipertension Y Riesgo Vascular
|
January 31, 2016
[Cardiovascular risk study in patients with renin-angiotensin system blockade by means of the proteone of circulating extracellular vesicles]
F de la Cuesta, M Baldan-Martin, L Mourino-Alvarez, et al.
Revista Clinica Espanola
|
August 9, 2001
[Control of arterial pressure: experience at a hospital monographic unit arterial hypertension]
J Segura de la Morena, C Campo Sien, M L Fernández López, et al.
Herz
|
July 1, 2006
ESH-ESC guidelines for the management of hypertension
Serap Erdine, Oben Ari, A Zanchetti, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
October 13, 2023
Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors
M Sanz-Gómez, F J Manzano-Lista, E Vega-Martín, et al.
Hipertension Y Riesgo Vascular
|
April 28, 2018
[Spanish Society of Hypertension position statement on the 2017 ACC/AHA hypertension guidelines]
T Gijón-Conde, M Gorostidi, M Camafort, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 284) with videos related to
Sort By:
Page
of 29
Journal of Hypertension
|
June 1, 1993
Antihypertensive activity of verapamil: impact of dietary sodium. The VERSAL Study Group
J Redón-Más, J Abellán-Alemán, P Aranda-Lara, et al.
Hypertension (Dallas, Tex. : 1979)
|
October 20, 2001
Impairment of renal vasodilation with l-arginine is related to more severe disease in untreated hypertensive patients
E Bello, C Caramelo, N Martell, et al.
Expert Review of Proteomics
|
June 15, 2019
Proteomic investigations into hypertension: what's new and how might it affect clinical practice?
N Corbacho-Alonso, E Rodríguez-Sánchez, T Martin-Rojas, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 3, 1999
Induction of microalbuminuria by l-arginine infusion in healthy individuals: an insight into the mechanisms of proteinuria
E Bello, C Caramelo, M D López, et al.
Journal of Human Hypertension
|
June 26, 2015
Modification over time of pulse wave velocity parallel to changes in aortic BP, as well as in 24-h ambulatory brachial BP
A Oliveras, J Segura, C Suarez, et al.
Hipertension Y Riesgo Vascular
|
January 31, 2016
[Cardiovascular risk study in patients with renin-angiotensin system blockade by means of the proteone of circulating extracellular vesicles]
F de la Cuesta, M Baldan-Martin, L Mourino-Alvarez, et al.
Revista Clinica Espanola
|
August 9, 2001
[Control of arterial pressure: experience at a hospital monographic unit arterial hypertension]
J Segura de la Morena, C Campo Sien, M L Fernández López, et al.
Herz
|
July 1, 2006
ESH-ESC guidelines for the management of hypertension
Serap Erdine, Oben Ari, A Zanchetti, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
October 13, 2023
Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors
M Sanz-Gómez, F J Manzano-Lista, E Vega-Martín, et al.
Hipertension Y Riesgo Vascular
|
April 28, 2018
[Spanish Society of Hypertension position statement on the 2017 ACC/AHA hypertension guidelines]
T Gijón-Conde, M Gorostidi, M Camafort, et al.
Page
of 29